HHS Seeks Rensselaer Research on Autism-Vaccine Links
- The Centers for Disease Control and prevention (CDC) announced on Thursday, September 11, 2025, its intention to fund research investigating a previously debunked link between vaccines and autism...
- The contract chance, posted on SAM.gov, details the research focus. It aims to explore the association between vaccination and autism prevalence,despite extensive evidence demonstrating no causal relationship.
- The pursuit of a link between vaccines and autism dates back to a 1998 paper published in The Lancet by Andrew Wakefield.
“`html
CDC to Fund Research into Debunked Vaccine-Autism Link, Reviving Trump-Era initiative
Table of Contents
Published September 12, 2025, at 18:34:07 EDT. Updated as needed.
What Happened
The Centers for Disease Control and prevention (CDC) announced on Thursday, September 11, 2025, its intention to fund research investigating a previously debunked link between vaccines and autism prevalence. The contract, initially solicited during the Trump administration, will be awarded to Rensselaer Polytechnic Institute (RPI) if finalized. This marks a significant shift, reviving a line of inquiry widely dismissed by the scientific community.
The contract chance, posted on SAM.gov, details the research focus. It aims to explore the association between vaccination and autism prevalence,despite extensive evidence demonstrating no causal relationship.
Why It Matters: A History of Discredited Claims
The pursuit of a link between vaccines and autism dates back to a 1998 paper published in The Lancet by Andrew Wakefield. This paper, later retracted by the journal and widely discredited due to fraudulent data and ethical violations, falsely claimed a connection between the measles, mumps, and rubella (MMR) vaccine and autism. Wakefield lost his medical license as a result.
Numerous studies conducted as then have consistently refuted any link between vaccines and autism.Organizations like the CDC, the World Health Organization (WHO), and the American Academy of Pediatrics (AAP) all affirm the safety and efficacy of vaccines and their lack of association with autism. Despite this consensus, the myth persists, fueled by misinformation and anti-vaccine sentiment.
Sole-Source Contract: Why RPI?
The contract is a sole-source award, meaning RPI was not required to compete with other institutions for the funding. This typically occurs when the goverment believes a specific institution possesses unique expertise or resources necessary for the research. The contract details suggest RPI has specific capabilities in analyzing large datasets related to vaccine and autism prevalence.
While sole-source contracts can be justified in certain circumstances, they raise concerns about transparency and potential bias.Critics argue that awarding the contract without competition could prioritize a specific research agenda over broader scientific consensus.
| Contract detail | Information |
|---|---|
| Agency | Centers for Disease Control and Prevention (CDC) |
| Recipient | Rensselaer Polytechnic Institute (RPI) |
| Contract Type | Sole-Source |
| Research Focus | Association between vaccination and autism prevalence |
| Contract Opportunity ID | 280398e7b4b54c0fac7de5efcbb80a80 |
expert Analysis
Timeline of the Vaccine-Autism Debate
- 1998: Andrew